SCHEMBL6991379

SCHEMBL6991379

CN(C(=O)c1nc2ccccc2nc1O)C1CCCc2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
HTT P42858 2/20 0.55
XBP1 P17861 1/20 0.55
RAB9A P51151 1/20 0.53
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
SPR P35270 2/20 0.46
TRPM8 Q7Z2W7 1/20 0.41
TAS2R14 Q9NYV8 1/20 0.41
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
KDM4E B2RXH2 1/20 0.38
P4HB P07237 1/20 0.38
P2RX3 P56373 2/20 0.38
P2RX2 Q9UBL9 2/20 0.38
CCR6 P51684 1/20 0.38
HTR6 P50406 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991183 0.76 HPGD (0.51) ALDH1A1HTTRAB9AMEN1KMT2A
SCHEMBL14299385 0.76 ALDH1A1 (0.70) ALDH1A1HTTXBP1RAB9AMEN1
SCHEMBL659024 0.76 ALDH1A1 (0.70) ALDH1A1HTTXBP1RAB9AMEN1
SCHEMBL8231768 0.74 ALDH1A1 (0.72) ALDH1A1HTTXBP1RAB9AMEN1
SCHEMBL9957488 0.74 ALDH1A1 (0.72) ALDH1A1HTTXBP1RAB9AMEN1
SCHEMBL11743947 0.74 ALDH1A1 (0.68) ALDH1A1HTTXBP1RAB9AMEN1
SCHEMBL18711851 0.72 ALDH1A1 (0.65) ALDH1A1HTTXBP1RAB9AMEN1
SCHEMBL19658774 0.72 ALDH1A1 (0.78) ALDH1A1HTTXBP1RAB9AMEN1
SCHEMBL18701634 0.72 ALDH1A1 (0.65) ALDH1A1HTTXBP1RAB9AMEN1
SCHEMBL13278581 0.72 ALDH1A1 (0.55) ALDH1A1HTTXBP1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889683-B2 Substituted quinoxalines as inhibitors of fatty acid binding protein MERCK SHARP & DOHME CORP. (US) 2014-11-18 US disclosed
US-8889683-B2 Substituted quinoxalines as inhibitors of fatty acid binding protein MERCK SHARP & DOHME CORP. (US) 2014-11-18 US disclosed
US-20120122837-A1 INHIBITORS OF FATTY ACID BINDING PROTEIN MERCK SHARP & DOHME LLC 2012-05-17 US disclosed
US-20120122837-A1 INHIBITORS OF FATTY ACID BINDING PROTEIN MERCK SHARP & DOHME LLC 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122837-A1 INHIBITORS OF FATTY ACID BINDING PROTEIN FABP4, FABP1, FABP3 ALDH1A1 1295/4885HTT 2628/4885XBP1 269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.